These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11422078)

  • 21. Neuropathy associated with lansoprazole treatment.
    Rajabally YA; Jacob S
    Muscle Nerve; 2005 Jan; 31(1):124-5. PubMed ID: 15468341
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole.
    Cockayne SE; Glet RJ; Gawkrodger DJ; McDonagh AJ
    Br J Dermatol; 1999 Jul; 141(1):173-5. PubMed ID: 10417548
    [No Abstract]   [Full Text] [Related]  

  • 23. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P; Fuchs W; Peifer-Weiss A; Simon B
    Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lansoprazole-induced hyponatremia].
    Fort E; Laurin C; Baroudi A; Liebaert-Bories MP; Strock P
    Gastroenterol Clin Biol; 2000; 24(6-7):686. PubMed ID: 10962399
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety profile of the proton-pump inhibitors.
    Reilly JP
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S11-7. PubMed ID: 10597119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lansoprazole and glottis edema.
    Pérez Roldán F; de los Ríos IL; Rodríguez Quinzaños E
    Am J Gastroenterol; 1999 Jul; 94(7):1995. PubMed ID: 10406293
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lansoprazole hypersensitivity syndrome].
    Baudot S; Milpied-Homsi B; Andres P; Poirier Y; Larousse C
    Therapie; 1999; 54(4):491-3. PubMed ID: 10667118
    [No Abstract]   [Full Text] [Related]  

  • 29. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
    Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
    Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymptomatic giardiasis--an association with proton pump inhibitors?
    Mukherjee S
    Am J Gastroenterol; 2000 Dec; 95(12):3666-7. PubMed ID: 11151928
    [No Abstract]   [Full Text] [Related]  

  • 32. Lansoprazole: in the management of gastroesophageal reflux disease in children.
    Scott LJ
    Paediatr Drugs; 2003; 5(1):57-61; discussion 62. PubMed ID: 12513106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [lymphocytic colitis associated with lansoprazole treatment].
    Ghilain JM; Schapira M; Maisin JM; De Maeght S; Piron A; Gerard R; Henrion J
    Gastroenterol Clin Biol; 2000 Oct; 24(10):960-2. PubMed ID: 11084433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apparent anaphylaxis associated with pantoprazole.
    Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
    Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
    [No Abstract]   [Full Text] [Related]  

  • 35. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug of the month. Lansoprazole (DakaR)].
    Scheen AJ
    Rev Med Liege; 1995 Mar; 50(3):133-4. PubMed ID: 7724943
    [No Abstract]   [Full Text] [Related]  

  • 37. [Galactorrhea induced by lansoprazole].
    Izquierdo Prieto OM; Moreno Alía E; Rosillo González A
    Aten Primaria; 2004 Oct; 34(6):325-6. PubMed ID: 15491529
    [No Abstract]   [Full Text] [Related]  

  • 38. [A clinical trial of lansoprazole in the treatment of duodenal ulcer].
    Pei Y; Wang B; Chen S
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):606-8. PubMed ID: 8697927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lansoprazole--another proton pump inhibitor.
    Drug Ther Bull; 1995 May; 33(5):36-7. PubMed ID: 7587993
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety of lansoprazole.
    Colin-Jones DG
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():56-60, discussion 61-6. PubMed ID: 8490081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.